Tome Biosciences goes public today in another biotech megaround

Off Biotech, biotechnology, Business, drug development, drug prices, drug pricing, genetics, government agencies, Health, Human Health, Life Sciences, Medicine, Pharma, policy, rare diseases, research, Science and Research, The Readout

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Hello, everyone. Damian here with an introduction to an emerging VC with a famous name, an escalation from the FTC, and the latest biotech megaround.

Read the rest…

Read Original Article: Tome Biosciences goes public today in another biotech megaround »

About The Author